Biotech



SBU, Cold Spring and BNL win hub grant

A $3 million grant from the National Institutes of Health will help Long Island’s three premier biotech R&D facilities speed medical breakthroughs to market. The NIH announced April 8 that…



Clinical trials for DepYMed

A joint venture between biotech stalwart Ohr Pharmaceutical and Cold Spring Harbor Laboratory is taking the fight to breast cancer – though a revolutionary treatment may still be a half-decade…


Ryan, former Forest veep, named to CSHL post

Cold Spring Harbor Laboratory has added another major-league bat to its commercialization lineup. Charles Ryan, former senior vice president and chief intellectual property counsel at Forest Laboratories, is CSHL’s new…